Pathomechanism of entrapment neuropathy in diabetic and nondiabetic rats reared in wire cages

Histology and Histopathology

Volumn 23, Issue 2, 2008, Pages 157-166

  Nishimura, Toshiko ^a   Hirata, Hitoshi ^b   Tsujii, Masaya ^a   Iida, Ryu ^a   Hoki, Yoko ^a   Iino, Takahiro ^a   Ogawa, Satoru ^a   Uchida, Atsumasa ^a  

^a MIE UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Mast cell; Neuropathy; Pathology; Streptozotocin; Tenascin C

Indexed keywords

ANIMALIA; RATTUS;

TENASCIN;

ANIMAL; ANIMAL HOUSING; ARTICLE; DIABETIC NEUROPATHY; ELECTROPHYSIOLOGY; EXPERIMENTAL DIABETES MELLITUS; FLUORESCENT ANTIBODY TECHNIQUE; GENE SILENCING; GLUCOSE BLOOD LEVEL; HINDLIMB; INNERVATION; MALE; METABOLISM; NERVE COMPRESSION; NERVE CONDUCTION; PATHOLOGY; PATHOPHYSIOLOGY; PERIPHERAL NERVE; RAT; REACTION TIME; TIBIAL NERVE; TRANSGENIC ANIMAL;

ANIMALS; ANIMALS, GENETICALLY MODIFIED; BLOOD GLUCOSE; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC NEUROPATHIES; ELECTROPHYSIOLOGY; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; GENE SILENCING; HINDLIMB; HOUSING, ANIMAL; MALE; NERVE COMPRESSION SYNDROMES; NEURAL CONDUCTION; PERIPHERAL NERVES; RATS; REACTION TIME; TENASCIN; TIBIAL NERVE;

EID: 38449091778     PISSN: 02133911     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Castellon R., Caballero S., Hamdi H.K., Atilano S.R., Aoki A.M., Tarnuzzer R.W., Kenney M.C., Grant M.B. and Ljubimov A.V. (2002). Effects of tenascin-C on normal and diabetic retinal endothelial cells in culture. Invest. Ophthalmol. Vis. Sci. 43, 2758-2766.
2. Chiquet-Ehrismann R., Tannheimer M., Koch M., Brunner A., Spring J., Martin D., Baumgartner S. and Chiquet M. (1994). Tenascin-C expression by fibroblasts is elevated in stressed collagen gels. J. Cell Biol. 127, 2093-2101.
3. Consensus statement (1988). Report and recommendations of the San Antonio conference on diabetic neuropathy. American Diabetes Association American Academy of Neurology. Diabetes Care. 11, 592-597.
4. Dellon A.L., Dellon E.S. and Seiler W.A. 4th. (1994). Effect of tarsal tunnel decompression in the streptozotocin-induced diabetic rat. Microsurgery 15, 265-268.
5. Dyck P.J. and Giannini C. (1996). Pathologic alterations in the diabetic neuropathies of humans: a review. J. Neuropathol. Exp. Neurol. 55,1181-1193.
6. Dyck P.J., Engelstad J.K., Giannini C., Lais A.C., Minnerath S.R. and Karnes J.L. (1989). Resistance to axonal degeneration after nerve compression in experimental diabetes. Proc. Natl. Acad. Sci. USA 86, 2103-2106.
7. Esposito B., De Santis A., Monteforte R. and Baccari G.C. (2002). Mast cells in Wallerian degeneration: morphologic and ultrastructural changes. J. Comp. Neurol. 8, 199-210.
8. Forcier N.J., Mizisin A.P., Rimmer M.A. and Powell H.C. (1991). Cellular pathology of the nerve microenvironment in galactose intoxication. J Neuropathol. Exp. Neurol. 50, 235-255.
9. Garcion E., Faissner A. and French-Constant C. (2001) Knockout mice reveal a contribution of the extracellular matrix molecule tenascin-C to neural precursor proliferation and migration. Development 128, 2485-2496.
10. Gilbert R.E., Rumble J.R., Cao Z., Cox A.J., van Eeden P., Allen T.J., Kelly D.J. and Cooper M.E. (2000). Endothelin receptor antagonism ameliorates mast cell infiltration, vascular hypertrophy, and epidermal growth factor expression in experimental diabetes. Circ Res.4, 158-165.
11. Gupta R., Rowshan K., Chao T., Mozaffar T. and Steward O. (2004). Chronic nerve compression induces local demyelination and remyelination in a rat model of carpal tunnel syndrome. Exp. Neurol. 187, 500-508.
12. Kale B., Yuksel F., Celikoz B., Sirvanci S., Ergun O. and Arbak S. (2003). Effect of various nerve decompression procedures on the functions of distal limbs in streptozotocin-induced diabetic rats: further optimism in diabetic neuropathy. Plast. Reconstr. Surg. 111, 2265-2272.
13. Lundborg G. (1988). Nerve injury and repair. Churchill Livingstone. London. pp 102-143.
14. Martini R., Schachner M. and Faissner A. (1990). Enhanced expression of the extracellular matrix molecule J1/tenascin in the regenerating adult mouse sciatic nerve. J. Neurocytol. 19, 601-616.
15. Medori R., Antilio-Gamgetti L., Jenich H. and Gambetti P. (1988). Changes in axon size and slow axonal transport are related in experimental diabetic neuropathy. Neurology 38, 597-601.
16. Mizisin A.P. and Powell H.C.(1993). Schwann cell injury is attenuated by aldose reductase inhibition in galactose intoxication. J. Neuropathol. Exp. Neurol. 52, 78-86.
17. Niwa Y., Kasugai T., Ohno K., Morimoto M., Yamazaki M., Dohmae K., Nishimune Y., Kondo K. and Kitamura Y. (1991). Anemia and mast cell depletion in mutant rats that are homozygous at "White spotting (Ws)"locus. Blood 15, 1936-1941.
18. Ruger B.M., Hasan Q., Greenhill N.S., Davis P.F., Dunbar P.R. and Neale T.J. (1996). Mast cells and type VIII collagen in human diabetic nephropathy. Diabetologia 39, 1215-1222.
19. Sima A.A. and Sugimoto K. (1999). Experimental diabetic neuropathy: an update. Diabetologia 42,773-788.
20. Sima A.A., Zhang W.X., Tze W.J., Tai J. and Nathaniel V. (1988). Diabetic neuropathy in STZ-induced diabetic rat and effect of allogeneic islet cell transplantation. Morphometric analysis. Diabetes 37, 1129-1136.
21. Skaper S.D., Pollock M. and Facci L. (2001). Mast cells differentially express and release active high molecular weight neurotrophins. Brain Res. Mol. Brain Res. 30, 177-185.
22. Tamaoki M., Imanaka-Yoshida K., Yokoyama K., Nishioka T., Inada H., Hiroe M., Sakakura T. and Yoshida T. (2005). Tenascin-C regulates recruitment of myofibroblasts during tissue repair after myocardial injury. Am. J. Pathol. 167, 71-80.
23. Tsujii M., Hirata H., Yoshida T., Imanaka-Yoshida K., Morita A. and Uchida A. (2006). Involvement of tenascin-C and PG-M/versican in flexor tenosynovial pathology of idiopathic carpal tunnel syndrome. Histol Histopathol. 21, 511-518.
24. Vinik A.I. and Mehrabyan A. (2004). Diabetic neuropathies. Med. Clin. North Am. 88, 947-999.
25. Yagihashi S. (1995). Pathology and pathogenetic mechanisms of diabetic neuropathy. Diabetes Metab. Rev. 11, 193-225.
26. Yagihashi S., Kamijo M., Ido Y. and Mirrlees D.J. (1990a). Effects of long-term aldose reductase inhibition on development of experimental diabetic neuropathy. Ultrastructural and morphometric studies of sural nerve in streptozocin-induced diabetic rats. Diabetes 39, 690-696.
27. Yagihashi S., Kamijo M. and Watanabe K. (1990b). Reduced myelinated fiber size correlates with loss of axonal neurofilaments in peripheral nerve of chronically streptozotocin diabetic rats. Am. J. Pathol. 136, 1365-1373.
28. Zochodne D.W. (1999). Diabetic neuropathies: features and mechanisms. Brain Pathol. 9, 369-391.
29. Zochodne D.W., Murray M.M., van der Sloot P. and Riopelle R.J. (1995). Distal tibial mononeuropathy in diabetic and nondiabetic rats reared on wire cages: an experimental entrapment neuropathy. Brain Res. 6, 130-136.